“There was a small but significantly higher glycerol Ra (measure of lipolysis) AUC0–180 min with dapagliflozin.”
“When divided by BMI >27 and <27 kg/m2, basal glucose Ra, BOHB, and glycerol Ra AUC0–180 min were significantly higher in the low-BMI group with dapagliflozin treatment versus the low-BMI group with placebo.”